Liquid-liquid phase separation of ATXN2L enhances mRNA translation in hepatocellular carcinoma

dc.contributor.authorWang, Shenghong
dc.contributor.authorGuo, Peilan
dc.contributor.authorMa, Wenqiang
dc.contributor.authorHuang, Honglin
dc.contributor.authorZhang, Qianqian
dc.contributor.authorWolczynski, Slawomir
dc.contributor.authorRahman, Nafis
dc.contributor.authorLiu, Jiali
dc.contributor.authorTsang, Suk-Ying
dc.contributor.authorDu, Xuguang
dc.contributor.authorWang, Fengchao
dc.contributor.authorGao, Jie
dc.contributor.authorLi, Xiangdong
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organization-code1.2.246.10.2458963.20.77952289591
dc.converis.publication-id505545094
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/505545094
dc.date.accessioned2026-01-21T14:30:53Z
dc.date.available2026-01-21T14:30:53Z
dc.description.abstract<p>RNA-binding proteins (RBPs) serve as key regulators of hepatocellular carcinoma (HCC); however, the specific mechanisms by which RBPs function in this context require clarification. Here, we identify an RBP, <em>ATXN2L</em> (ataxin 2-like), that is significantly upregulated in HCC tissues and correlates with a poor prognosis. Knockdown of <em>ATXN2L</em> in HCC cells or knockout of <em>Atxn2l</em> in mice suppresses HCC progression. Mechanistically, enhanced liquid-liquid phase separation (LLPS) activity of ATXN2L results in the formation of larger ATXN2L-positive granules, which facilitate the recruitment of several eukaryotic initiation factors (eIFs) and their downstream targets, such as <em>ADAM9</em> (ADAM metallopeptidase domain 9), thereby promoting mRNA translation. Moreover, the promotion of ATXN2L granules on <em>ADAM9</em> translation is further enhanced via co-localization with stress granules (SGs). Together, our findings reveal that ATXN2L functions as a critical translational regulator in HCC progression through LLPS activity, which could serve as an effective therapeutic target for HCC treatment.<br></p>
dc.identifier.eissn2211-1247
dc.identifier.jour-issn2211-1247
dc.identifier.olddbid213364
dc.identifier.oldhandle10024/196382
dc.identifier.urihttps://www.utupub.fi/handle/11111/55254
dc.identifier.urlhttps://doi.org/10.1016/j.celrep.2025.116588
dc.identifier.urnURN:NBN:fi-fe202601215484
dc.language.isoen
dc.okm.affiliatedauthorRahman, Nafis
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherElsevier BV
dc.publisher.countryNetherlandsen_GB
dc.publisher.countryAlankomaatfi_FI
dc.publisher.country-codeNL
dc.relation.articlenumber116588
dc.relation.doi10.1016/j.celrep.2025.116588
dc.relation.ispartofjournalCell Reports
dc.relation.issue12
dc.relation.volume44
dc.source.identifierhttps://www.utupub.fi/handle/10024/196382
dc.titleLiquid-liquid phase separation of ATXN2L enhances mRNA translation in hepatocellular carcinoma
dc.year.issued2025

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
1-s2.0-S0753332225009850-main.pdf
Size:
8.59 MB
Format:
Adobe Portable Document Format